Terms: = Breast cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
101 results:
1. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
2. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-ap1 axis.
Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
[TBL] [Abstract] [Full Text] [Related]
3. Targeting c-jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
[TBL] [Abstract] [Full Text] [Related]
5. The Role of FBXW7 in Gynecologic Malignancies.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
Cells; 2023 May; 12(10):. PubMed ID: 37408248
[TBL] [Abstract] [Full Text] [Related]
6. Targeting c-jun Is a Potential Therapy for Luminal breast cancer Bone Metastasis.
Han Y; Katayama S; Futakuchi M; Nakamichi K; Wakabayashi Y; Sakamoto M; Nakayama J; Semba K
Mol Cancer Res; 2023 Sep; 21(9):908-921. PubMed ID: 37310848
[TBL] [Abstract] [Full Text] [Related]
7. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/Yap1/c-jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
8. Icariin Induces Triple-Negative breast cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-jun Signaling Pathway.
Gao S; Zhang X; Liu J; Ji F; Zhang Z; Meng Q; Zhang Q; Han X; Wu H; Yin Y; Lv Y; Shi W
Drug Des Devel Ther; 2023; 17():821-836. PubMed ID: 36969705
[TBL] [Abstract] [Full Text] [Related]
9. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
10. Tanshinone IIA Inhibits Triple-Negative breast cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
[TBL] [Abstract] [Full Text] [Related]
11. Integrative analyses of radiation-related genes and biomarkers associated with breast cancer.
Dan WC; Guo XY; Zhang GZ; Wang SL; Deng M; Liu JL
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):256-274. PubMed ID: 36647876
[TBL] [Abstract] [Full Text] [Related]
12. Transcription factor c-jun modulates GLUT1 in glycolysis and breast cancer metastasis.
Zhu P; Liu G; Wang X; Lu J; Zhou Y; Chen S; Gao Y; Wang C; Yu J; Sun Y; Zhou P
BMC Cancer; 2022 Dec; 22(1):1283. PubMed ID: 36476606
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-217 aggravates breast cancer through activation of NF1-mediated HSF1/ATG7 axis and c-jun/ATF3/MMP13 axis.
Li W; Yang C; Li J; Li X; Zhou P
Hum Cell; 2023 Jan; 36(1):377-392. PubMed ID: 36357766
[TBL] [Abstract] [Full Text] [Related]
14. Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification.
Lin X; Lin X; Guo L; Wang Y; Zhang G
Thorac Cancer; 2022 Dec; 13(24):3441-3450. PubMed ID: 36305094
[TBL] [Abstract] [Full Text] [Related]
15. FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy.
Zeng F; He J; Jin X; Liao Q; Chen Z; Peng H; Zhou Y
Biomed Pharmacother; 2022 Jun; 150():113037. PubMed ID: 35658206
[TBL] [Abstract] [Full Text] [Related]
16. Screening of genes related to breast cancer prognosis based on the DO-UniBIC method.
Zhang F; Zhang Y; Hou T; Ren F; Liu X; Zhao R; Zhang X
Am J Med Sci; 2022 Sep; 364(3):333-342. PubMed ID: 35472336
[TBL] [Abstract] [Full Text] [Related]
17. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
18. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract] [Full Text] [Related]
19. Integrative investigation of the TF-miRNA coregulatory network involved in the inhibition of breast cancer cell proliferation by resveratrol.
Zhou Y; Zhang J; Li W; Zhang D; Wang Z; Zhai Y; Yu H; Li Z
FEBS Open Bio; 2022 Feb; 12(2):379-393. PubMed ID: 34856073
[TBL] [Abstract] [Full Text] [Related]
20. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative breast cancer.
Harris RJ; Cheung A; Ng JCF; Laddach R; Chenoweth AM; Crescioli S; Fittall M; Dominguez-Rodriguez D; Roberts J; Levi D; Liu F; Alberts E; Quist J; Santaolalla A; Pinder SE; Gillett C; Hammar N; Irshad S; Van Hemelrijck M; Dunn-Walters DK; Fraternali F; Spicer JF; Lacy KE; Tsoka S; Grigoriadis A; Tutt ANJ; Karagiannis SN
Cancer Res; 2021 Aug; 81(16):4290-4304. PubMed ID: 34224371
[TBL] [Abstract] [Full Text] [Related]
[Next]
